12 September 2020 : Case report
Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders
Rare coexistence of disease or pathology
DOI: 10.12659/AJCR.927418
Am J Case Rep 2020; 21:e927418